Importantly, in high risk/advanced PC patients the current gold standard technique for PSMA detection is a whole-body imaging with positron emission tomography (PET) using small amounts of radioactive tracers, such as 68Ga-PSMA-11 [79]. This evidence concerns the gene FOLH1 and pachyonychia congenita.